Literature DB >> 11863473

Physician-related barriers to the effective management of uncontrolled hypertension.

Susan A Oliveria1, Pablo Lapuerta, Bruce D McCarthy, Gilbert J L'Italien, Dan R Berlowitz, Steven M Asch.   

Abstract

BACKGROUND: Primary care physicians may not be aggressive enough with the management of hypertension. The purpose of this study was to identify barriers to primary care physicians' willingness to increase the intensity of treatment among patients with uncontrolled hypertension.
METHODS: Descriptive survey study. We sampled patient visits in a large midwestern health system to identify patients with uncontrolled hypertension. The treating primary care physicians were asked to complete a survey about the patient visit with a copy of the office notes attached to the survey (patient visits, n = 270; response rate, 86%).
RESULTS: Pharmacologic therapy was initiated or changed at only 38% of visits, despite documented hypertension for at least 6 months before the patients' most recent visit. The most frequently cited reason for no initiation or change in therapy was related to the primary care physicians being satisfied with the blood pressure (BP) value (satisfactory BP response, 30%; satisfactory diastolic BP response, 16%; only borderline hypertension, 10%). At 93% of these visits, systolic BP values were 140 mm Hg or higher, which is above the cut point recommended by Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure guidelines, and 35% were 150 mm Hg or higher. On average, physicians reported that 150 mm Hg was the lowest systolic BP at which they would recommend pharmacologic treatment to patients, compared with 91 mm Hg for diastolic BP.
CONCLUSIONS: Our findings suggest that an important reason why physicians do not treat hypertension more aggressively is that they are willing to accept an elevated systolic BP in their patients. This has an important impact on public health because of the positive association between systolic BP and cardiovascular disease.

Entities:  

Mesh:

Year:  2002        PMID: 11863473     DOI: 10.1001/archinte.162.4.413

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  132 in total

1.  Quality measurement as a prerequisite for improving hypertension control in an academic medical center.

Authors:  Fani E Syrrokosta; Konstantinos M Lampropoulos; Ioannis Papargyriou; Dimitrios Papadogiannis
Journal:  Clin Cardiol       Date:  2011-12-07       Impact factor: 2.882

2.  Nurse-led disease management for hypertension control in a diverse urban community: a randomized trial.

Authors:  Paul L Hebert; Jane E Sisk; Leah Tuzzio; Jodi M Casabianca; Velvie A Pogue; Jason J Wang; Yingchun Chen; Christine Cowles; Mary Ann McLaughlin
Journal:  J Gen Intern Med       Date:  2011-12-06       Impact factor: 5.128

3.  Disease management to promote blood pressure control among African Americans.

Authors:  Troyen Brennan; Claire Spettell; Victor Villagra; Elizabeth Ofili; Cheryl McMahill-Walraven; Elizabeth J Lowy; Pamela Daniels; Alexander Quarshie; Robert Mayberry
Journal:  Popul Health Manag       Date:  2010-04       Impact factor: 2.459

4.  A cluster-randomized effectiveness trial of a physician-pharmacist collaborative model to improve blood pressure control.

Authors:  Barry L Carter; William Clarke; Gail Ardery; Cynthia A Weber; Paul A James; Mark Vander Weg; Elizabeth A Chrischilles; Thomas Vaughn; Brent M Egan
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2010-07

5.  Increasing collaboration between health professionals: Clues and challenges.

Authors:  Nelson Alberto Aguirre-Duarte
Journal:  Colomb Med (Cali)       Date:  2015-06-30

6.  The Canadian Hypertension Education Program--a unique Canadian initiative.

Authors:  F A McAlister
Journal:  Can J Cardiol       Date:  2006-05-15       Impact factor: 5.223

7.  The Canadian Hypertension Education Program (CHEP) recommendations: launching a new series.

Authors:  Finlay A McAlister; Eric Wooltorton; Norman R C Campbell
Journal:  CMAJ       Date:  2005-08-30       Impact factor: 8.262

8.  Therapy modifications in response to poorly controlled hypertension, dyslipidemia, and diabetes mellitus.

Authors:  Nicolas Rodondi; Tiffany Peng; Andrew J Karter; Douglas C Bauer; Eric Vittinghoff; Simon Tang; Daniel Pettitt; Eve A Kerr; Joe V Selby
Journal:  Ann Intern Med       Date:  2006-04-04       Impact factor: 25.391

9.  Description of pharmacist interventions during physician-pharmacist co-management of hypertension.

Authors:  Shannon J Von Muenster; Barry L Carter; Cynthia A Weber; Michael E Ernst; Jessica L Milchak; Jennifer J G Steffensmeier; Yinghui Xu
Journal:  Pharm World Sci       Date:  2007-08-21

10.  Development and validation of the hyperlipidemia: attitudes and beliefs in treatment (HABIT) survey for physicians.

Authors:  Kathleen A Foley; Joseph Vasey; Charles M Alexander; Leona E Markson
Journal:  J Gen Intern Med       Date:  2003-12       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.